StockMacro
Menu

Strata Critical Medical

$4.56 -26% in 6 monthsMarket cap $407.3M

SRTA on XNAS, Transportation, Strata Critical Medical, Inc., job postings

Measures activity, not value. Not investment advice.

Quarterly revenue jumped 50% to $74.1M but the stock is down 26% in six months.

  • BadStill lost $24.8M over the last 12 months
  • GoodInstitutional holders rose 18% to 164 from the prior quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

Industry
Transportation services (Transportation)
Employees
601
Website
stratacritical.com
Listed
Nasdaq, US
Last results
3 Nov 2026
Next results
expected around 2 Mar 2027 (an estimate: a year ago it reported on 3 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $74.1M, net loss $7.6M.
Quarter to 31 Dec 2021: revenue $24.6M, net income $772KQuarter to 31 Dec 2021: revenue $24.6M, net income $772KQuarter to 31 Mar 2022: revenue $26.6M, net income -$11.0MQuarter to 31 Mar 2022: revenue $26.6M, net income -$11.0MQuarter to 30 Jun 2022: revenue $35.6M, net income $8.4MQuarter to 30 Jun 2022: revenue $35.6M, net income $8.4MQuarter to 30 Sep 2022: revenue $45.7M, net income -$9.2MQuarter to 30 Sep 2022: revenue $45.7M, net income -$9.2MQuarter to 31 Dec 2022: revenue $38.1M, net income -$27.3MQuarter to 31 Dec 2022: revenue $38.1M, net income -$27.3MQuarter to 31 Mar 2023: revenue $45.3M, net income -$10.2MQuarter to 31 Mar 2023: revenue $45.3M, net income -$10.2MQuarter to 30 Jun 2023: revenue $61.0M, net income -$12.2MQuarter to 30 Jun 2023: revenue $61.0M, net income -$12.2MQuarter to 30 Sep 2023: revenue $71.4M, net income $289KQuarter to 30 Sep 2023: revenue $71.4M, net income $289KQuarter to 31 Dec 2023: revenue $47.5M, net income -$33.9MQuarter to 31 Dec 2023: revenue $47.5M, net income -$33.9MQuarter to 31 Mar 2024: revenue $51.5M, net income -$4.2MQuarter to 31 Mar 2024: revenue $51.5M, net income -$4.2MQuarter to 30 Jun 2024: revenue $67.9M, net income -$11.3MQuarter to 30 Jun 2024: revenue $67.9M, net income -$11.3MQuarter to 30 Sep 2024: revenue $74.9M, net income -$2.0MQuarter to 30 Sep 2024: revenue $74.9M, net income -$2.0MQuarter to 31 Dec 2024: revenue $54.4M, net income -$9.8MQuarter to 31 Dec 2024: revenue $54.4M, net income -$9.8MQuarter to 31 Mar 2025: revenue $54.3M, net income -$3.5MQuarter to 31 Mar 2025: revenue $54.3M, net income -$3.5MQuarter to 30 Jun 2025: revenue $70.8M, net income -$3.7MQuarter to 30 Jun 2025: revenue $70.8M, net income -$3.7MQuarter to 30 Sep 2025: revenue $49.3M, net income $57.4MQuarter to 30 Sep 2025: revenue $49.3M, net income $57.4MQuarter to 31 Dec 2025: revenue –, net income -$8.8MQuarter to 31 Mar 2026: revenue $67.4M, net income $2.2MQuarter to 31 Mar 2026: revenue $67.4M, net income $2.2MQuarter to 30 Jun 2026: revenue $72.5M, net income -$10.5MQuarter to 30 Jun 2026: revenue $72.5M, net income -$10.5MQuarter to 30 Sep 2026: revenue $74.1M, net income -$7.6MQuarter to 30 Sep 2026: revenue $74.1M, net income -$7.6M
31 Dec 2021RevenueNet incomeNet losstallest bar $74.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$74.1M-$7.6M
30 Jun 2026$72.5M-$10.5M
31 Mar 2026$67.4M$2.2M
31 Dec 2025–-$8.8M
30 Sep 2025$49.3M$57.4M
30 Jun 2025$70.8M-$3.7M
31 Mar 2025$54.3M-$3.5M
31 Dec 2024$54.4M-$9.8M
30 Sep 2024$74.9M-$2.0M
30 Jun 2024$67.9M-$11.3M
31 Mar 2024$51.5M-$4.2M
31 Dec 2023$47.5M-$33.9M
30 Sep 2023$71.4M$289K
30 Jun 2023$61.0M-$12.2M
31 Mar 2023$45.3M-$10.2M
31 Dec 2022$38.1M-$27.3M
30 Sep 2022$45.7M-$9.2M
30 Jun 2022$35.6M$8.4M
31 Mar 2022$26.6M-$11.0M
31 Dec 2021$24.6M$772K
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $280.8M $184.7M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +52% +9.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$24.8M $40.4M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.30 $0.49
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 21.6% 21.3% 18.7%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -6.6% -13.2% 4.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -8.8% 21.9% 1.0%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -8.9% -5.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$54.7M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $41.6M $75.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – -$75.9M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 1.3
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.09
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 16.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.5 2.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.7
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.5 1.7

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Strata Critical MedicalSRTA (this company) $407.3Mloss1.5+52%-8.8%
GMR SolutionsGMRS $675.0M––––
Verra MobilityVRRM $243.2M6.40.24+6.5%3.8%
Virgin GalacticSPCE $157.7Mloss143-34%–
Lindblad ExpeditionsLIND $2.0B3442.3+17%0.7%
Proficient Auto LogisticsPAL $76.6Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$10K

bought $10K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+18%

164 13F filers vs 139

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

63%

55.9M shares held by 13F filers (30 Sep 2026) of 89.3M outstanding (26 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.1%

4.6M shares sold short (30 Oct 2026) of 89.3M outstanding (26 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.0

4.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+0.3%

4.5M shares sold short in the report before, 4.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

61%

61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 47%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

22

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+50%

$74.1M vs $49.3M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-86%

$400K vs $2.8M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$120K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

6

6 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

2.0×

6 articles in the last 7 days; its usual week has 3.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New institutional positions 47, 2.0× a year earlier

Price $4.56 on 20 Nov 2026, +13% over 12 months (12-month range $4.03 to $6.47)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $724K in the last 12 months (the 12 months before: -$2.7M).
Revenue per quarter. Revenue $74.1M in the latest quarter, +50% on a year earlier.
Capital spending per quarter. Capital spending $400K in the latest quarter, -86% on a year earlier.
Institutional holders (13F filers). 164 13F filers reported holding it in the latest 13F quarter, +28% on a year earlier.
Lobbying spend. Lobbying spend: $120K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeMany funds opening a new position: many funds opening a new position, 47 vs usual 16 (2026-09-30); 2.0x the same period a year earlier
20 Apr 2026Sharp changeLobbying on a new issue: lobbying on a new issue: HCR (2026-03-31)
16 Apr 2026Lobbying filingnew lobbying registration (INTEGRUS STRATEGIES, LLC)
6 Apr 2026Lobbying filingnew lobbying registration (AXADVOCACY GOVERNMENT RELATIONS)
3 Dec 20258-K and other filingsDirector or officer change
3 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Sep 20258-K and other filingsCompleted an acquisition or asset sale
29 Aug 20258-K and other filingsCompleted an acquisition or asset sale
29 Aug 20258-K and other filingsDirector or officer change
4 Aug 20258-K and other filingsDirector or officer change
4 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Nov 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 9.3M vs usual 670K (2024-09-30); 13.4x the same period a year earlier
13 Aug 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 16.2M vs usual 542K (2024-06-30); 21.7x the same period a year earlier
22 Mar 20248-K and other filingsChanged its auditor
20 Jul 2023Lobbying filinglobbying engagement terminated (MS. MICHELLE NAWAR)
20 Jul 2023Lobbying filinglobbying engagement terminated (BOLTON-ST. JOHNS, LLC)
30 Mar 20238-K and other filingsDirector or officer change
30 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 45.7M vs usual 13.0M (2022-09-30); 2.3x the same period a year earlier
2 Jun 2022Lobbying filingnew lobbying registration (MS. MICHELLE NAWAR)
1 Jun 2022Lobbying filingnew lobbying registration (BOLTON-ST. JOHNS, LLC)
14 Jan 2022Lobbying filinglobbying engagement terminated (INVARIANT LLC)
Insider net buying (open market)
Month from 1 May 2022: -$3.3M published
Month from 1 Jun 2022: -$2.5M published
Month from 1 Aug 2022: -$2.1M published
Month from 1 Sep 2022: -$239K published
Month from 1 Oct 2022: -$81K published
Month from 1 Nov 2022: -$139K published
Month from 1 Dec 2022: -$36K published
Month from 1 Jan 2023: -$80K published
Month from 1 Apr 2023: -$562K published
Month from 1 Jul 2023: -$1.5M published
Month from 1 Sep 2023: -$36K published
Month from 1 Oct 2023: -$450K published
Month from 1 Nov 2023: $96K published
Month from 1 Dec 2023: -$562K published
Month from 1 Mar 2024: -$677K published
Month from 1 Apr 2024: -$240K published
Month from 1 Jun 2024: $5K published
Month from 1 Sep 2024: -$36K published
Month from 1 Nov 2024: -$7.4M published
Month from 1 Dec 2024: -$808K published
Month from 1 Jan 2025: -$525K published
Month from 1 Jun 2025: -$815K published
Month from 1 Aug 2025: -$469K published
Month from 1 Nov 2025: -$95K published
Month from 1 Dec 2025: $98K published
Month from 1 May 2026: -$382K published
Month from 1 Jun 2026: -$420K published
Month from 1 Aug 2026: -$29K published
Month from 1 Nov 2026: $10K published
Revenue per quarter
Quarter ended 30 Sep 2020: $8.3M; public on 21 Dec 2021
Quarter ended 31 Mar 2021: $9.3M; public on 11 May 2022
Quarter ended 30 Sep 2021: $20.3M, +144% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2021: $24.6M; public on 17 Mar 2023
Quarter ended 31 Mar 2022: $26.6M, +187% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $35.6M, +175% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $45.7M, +125% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $38.1M, +55% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $45.3M, +70% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $61.0M, +71% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $71.4M, +56% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $47.5M, +24% on a year earlier; public on 13 Mar 2024
Quarter ended 31 Mar 2024: $51.5M, +14% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $67.9M, +11% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $74.9M, +4.8% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $54.4M, +14% on a year earlier; public on 14 Mar 2025
Quarter ended 31 Mar 2025: $54.3M, +5.4% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $70.8M, +4.2% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $49.3M, -34% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Mar 2026: $67.4M, +24% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $72.5M, +2.4% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $74.1M, +50% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $53K; public on 11 May 2022
Quarter ended 30 Jun 2021: $144K; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $67K; public on 11 Nov 2022
Quarter ended 31 Dec 2021: $224K; public on 17 Mar 2023
Quarter ended 31 Mar 2022: $437K, +725% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $189K, +31% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $93K, +39% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $11K, -95% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $646K, +48% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $744K, +294% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $695K, +647% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Mar 2024: $816K, +26% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $16.2M, +2072% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $9.3M, +1240% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $4.6M; public on 14 Mar 2025
Quarter ended 31 Mar 2025: $2.6M, +221% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $2.3M, -86% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $2.8M, -70% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $1.8M, -60% on a year earlier; public on 4 Mar 2026
Quarter ended 31 Mar 2026: $5.2M, +98% on a year earlier; public on 7 May 2026
Quarter ended 30 Sep 2026: $400K, -86% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 74; public on 14 Feb 2022
31 Mar 2022 report: 74; public on 16 May 2022
30 Jun 2022 report: 91; public on 15 Aug 2022
30 Sep 2022 report: 94; public on 14 Nov 2022
31 Dec 2022 report: 85; public on 14 Feb 2023
31 Mar 2023 report: 86; public on 15 May 2023
30 Jun 2023 report: 83; public on 14 Aug 2023
30 Sep 2023 report: 94; public on 14 Nov 2023
31 Dec 2023 report: 92; public on 14 Feb 2024
31 Mar 2024 report: 106; public on 15 May 2024
30 Jun 2024 report: 106; public on 14 Aug 2024
30 Sep 2024 report: 115; public on 14 Nov 2024
31 Dec 2024 report: 117; public on 14 Feb 2025
31 Mar 2025 report: 115; public on 15 May 2025
30 Jun 2025 report: 117; public on 14 Aug 2025
30 Sep 2025 report: 128; public on 14 Nov 2025
31 Dec 2025 report: 120; public on 17 Feb 2026
31 Mar 2026 report: 122; public on 15 May 2026
30 Jun 2026 report: 139; public on 14 Aug 2026
30 Sep 2026 report: 164; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Jul 2022: $30K published
Quarter from 1 Oct 2022: $30K published
Quarter from 1 Jan 2023: $30K published
Quarter from 1 Apr 2023: $20K published
Quarter from 1 Jul 2023: $5K published
Quarter from 1 Apr 2026: $40K published
Quarter from 1 Jul 2026: $40K published
Quarter from 1 Oct 2026: $40K published

What is unusual now

  • Made public in the last 90 days: it saw 47 13F filers open a new position in the quarter ended 30 Sep 2026, 2.0× the same quarter last year.
  • Many funds opening a new position: saw 47 13F filers open a new position in the quarter ended 30 Sep 2026, 2.0× the same quarter last year Public on 16 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $724K in the last 12 months (the 12 months before: -$2.7M).
  • Revenue per quarter: Revenue $74.1M in the latest quarter, +50% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 83 insider trades

Last 90 days: no sales; 1 purchase, $10K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Nov 2026Andrew LauckDirectorBuy2,000$5.00$10KForm 4
13 Aug 2026Reginald LoveDirectorSell5,091$5.75$29KForm 4
10 Jun 2026William A. HeyburnCo-CEO and CFOSell31,671$5.87$186KForm 4
10 Jun 2026Scott M WunschCEO, LogisticsSell5,550$5.87$33KForm 4
10 Jun 2026Amir CohenChief Accounting OfficerSell4,655$5.87$27KForm 4
10 Jun 2026Melissa M. TomkielCo-CEO and General CounselSell29,730$5.87$175KForm 4
26 May 2026Amir CohenChief Accounting OfficerSellplanned in advance (10b5-1)50,875$5.89$299KForm 4
13 May 2026Amir CohenChief Accounting OfficerSellplanned in advance (10b5-1)14,306$5.79$83KForm 4

164 institutions reported shares at the end of Q3 2026, 63% of the shares outstanding; 47 opened a position, 21 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Third Point LLC5.0M5.60%$25.6MNo change
BlackRock, Inc.4.9M5.45%$24.9M+30K+0.6%
Northern Right Capital Management, L.P.4.5M5.01%$22.8M-420K-8.6%
Royce & Associates LP3.1M3.52%$16.1M+15K+0.5%
Vanguard Capital Management LLC2.9M3.25%$14.8M+16K+0.5%
AWM Investment Company, Inc.2.8M3.16%$14.4MNo change
Pillsbury Lake Capital LLC2.6M2.89%$13.2M+407K+19%
First Eagle Investment Management, LLC2.4M2.71%$12.4M-2.2M-48%
Hurricane Capital Advisors LLC2.4M2.70%$12.3M+150K+6.6%
Geode Capital Management, LLC1.8M2.07%$9.4M+91K+5.2%

Company events

All 26 company events

In 12 months: 1 director or officer change, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
5 Feb 2026Signed a major agreement8-K
3 Dec 2025Director or officer change8-K
16 Sep 2025Signed a major agreement; Completed an acquisition or asset saleSame filing: sold shares privately8-K
29 Aug 2025Director or officer change; Signed a major agreement; Completed an acquisition or asset saleSame filing: changed its bylaws or fiscal year8-K
4 Aug 2025Director or officer change; Signed a major agreement8-K
22 Mar 2024Changed its auditor8-K
30 Mar 2023Director or officer change; Signed a major agreement8-K
19 May 2022Signed a major agreement8-K

22 open postings; careers site tracked since 20 Nov 2026. Most in Supply chain & procurement 23%, SRE, DevOps & infrastructure 14%, Legal, policy & compliance 9%, Operations & administration 9%.

PostedJobLocation
19 Nov 2026Chief Perfusionist - Fort Myers, FLFort Myers, Florida, United States
19 Nov 2026Chief Perfusionist - Atlantic City, NJSRE, DevOps & infrastructureAtlantic City, New Jersey, United States
19 Nov 2026Medical Transportation Driver - Chandler, AZSupply chain & procurementChandler, Arizona, United States
16 Nov 2026Commercial Sales Program SpecialistSales & business developmentChandler, Arizona, United States; New York, NY, USA
13 Nov 2026Part-Time Emergency Transportation Driver - Milwaukee, WISupply chain & procurementMilwaukee, Wisconsin, United States
10 Nov 2026Medical Transportation Driver- PT- Fargo, NDSupply chain & procurementFargo, North Dakota, United States
10 Nov 2026Clinical Accounts Receivable SpecialistFinance & accountingChandler, Arizona, United States
4 Nov 2026ECMO Specialist | HealthPark Medical Center - Fort Myers, FLSupply chain & procurementFort Myers, Florida, United States

Reported lobbying spend: $40K in Q3 2026, $40K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jan 2026NewIntegrus Strategies, LLCfor Axadvocacy Government Relations On Behalf Of Strata CriticalIssues related to FAA regulations governing Part 135 operations, including duty and rest requirements for organ transportation flights. Issues related to healthcare policy affecting organ transplant logistics and services.Aviation, Health issues, TransportationFiling
1 Jan 2026NewAxadvocacy Government Relationsfor Strata CriticalIssues related to FAA regulations governing Part 135 operations, including duty and rest requirements for organ transportation flights. Issues related to healthcare policy affecting organ transplant logistics and services.Aviation, Health issues, TransportationFiling
30 Apr 2023EndedMs. Michelle Nawarfor Bolton-St. Johns LLC On Behalf Of Blade Air Mobility, Inc.Monitoring and outreach related to: -H.R.1071, Safe and Quiet Skies Act; -H.R.1257, Reducing Helicopter Noise in the District of Columbia Act; -H.R. 3921, Reduce Excessive Decibels and Unwanted Commotion and Emissions to Heighten Enforcement and Limitation of Intrusive Chopper Operations to ProtectAviation, CAW, TransportationFiling
30 Apr 2023EndedBolton-St. Johns, LLCfor Blade Air Mobility, Inc.Monitoring and outreach related to: -H.R.1071, Safe and Quiet Skies Act; -H.R.1257, Reducing Helicopter Noise in the District of Columbia Act; -H.R. 3921, Reduce Excessive Decibels and Unwanted Commotion and Emissions to Heighten Enforcement and Limitation of Intrusive Chopper Operations to ProtectAviation, CAW, TransportationFiling
10 May 2022NewMs. Michelle Nawarfor Bolton-St. Johns LLC On Behalf Of Blade Air Mobility, Inc.Issues related to H.R. 1643, Improving Helicopter Safety Act of 2021. Issues related to H.R. 7769, To establish a commission to develop a helicopter usage management plan for certain airspace, and for other purposes.Aviation, TransportationFiling
10 May 2022NewBolton-St. Johns, LLCfor Blade Air Mobility, Inc.Issues related to H.R. 1643, Improving Helicopter Safety Act of 2021. Issues related to H.R. 7769, To establish a commission to develop a helicopter usage management plan for certain airspace, and for other purposes.Aviation, TransportationFiling
1 Nov 2021EndedInvariant LLCfor Blade Urban Air Mobility, Inc.Educate Members of Congress on urban air mobility issues and eVTOL.AviationFiling
7 Jun 2021NewInvariant LLCfor Blade Urban Air Mobility, Inc.Educate Members of Congress on urban air mobility issues.Transportation, AviationFiling

The 5 newest of 153 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Institutional holdings change

    saw 47 13F filers open a new position in the quarter ended 30 Sep 2026, 2.0× the same quarter last year.

    Same quarter last year: 23; its normal quarter is 16.

    See the evidence
    This period
    47 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    16
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +7.0
    Same quarter last year
    23
    History used
    2,009 days
    2024-09-30: 162024-12-31: 122025-03-31: 142025-06-30: 232025-09-30: 232025-12-31: 142026-03-31: 162026-06-30: 312026-09-30: 47
    the quarter ended 30 Sep 20268 earlier quartersnormal: 16

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  2. 9 Nov 2026Insiders record

    LAUCK ANDREW (director) bought 2,000 shares of SRTA ($9,998)

  3. 20 Apr 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['HCR']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    11158131
  4. 16 Apr 2026Lobbying record

    AXADVOCACY GOVERNMENT RELATIONS ON BEHALF OF STRATA CRITICAL: new lobbying registration (INTEGRUS STRATEGIES, LLC) (dated 1 Jan 2026)

  5. 6 Apr 2026Lobbying record

    STRATA CRITICAL: new lobbying registration (AXADVOCACY GOVERNMENT RELATIONS) (dated 1 Jan 2026)

  6. 11 Dec 2025Insiders record

    Heyburn William A. (Co-CEO and CFO) bought 17,000 shares of SRTA ($75,990) (dated 10 Dec 2025)

  7. 6 Dec 2025Insiders record

    LAUCK ANDREW (director) bought 5,000 shares of SRTA ($21,850) (dated 5 Dec 2025)

  8. 3 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 3 Dec 2025Filings record

    Director or officer change

  10. 16 Sep 2025Filings record

    Completed an acquisition or asset sale

  11. 29 Aug 2025Filings record

    Director or officer change

  12. 29 Aug 2025Filings record

    Completed an acquisition or asset sale

  13. 4 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 4 Aug 2025Filings record

    Director or officer change

  15. 19 Nov 2024Financials change

    spent $9.3M on capital projects in the quarter ended 30 Sep 2024, 13× the same quarter last year.

    Same quarter last year: $695K; its normal quarter is $670K.

    See the evidence
    This period
    $9.3M (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    $670K
    Typical spread (median absolute deviation)
    $314K
    How far from its usual level
    +8.6
    Same quarter last year
    $695K
    History used
    1,279 days
    2022-06-30: $189K2022-09-30: $93K2022-12-31: $11K2023-03-31: $646K2023-06-30: $744K2023-09-30: $695K2024-03-31: $816K2024-06-30: $16.2M2024-09-30: $9.3M
    the quarter ended 30 Sep 20248 earlier quartersnormal: $670K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  16. 13 Aug 2024Financials change

    spent $16.2M on capital projects in the quarter ended 30 Jun 2024, 22× the same quarter last year.

    Same quarter last year: $744K; its normal quarter is $542K.

    See the evidence
    This period
    $16.2M (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    $542K
    Typical spread (median absolute deviation)
    $238K
    How far from its usual level
    +15.6
    Same quarter last year
    $744K
    History used
    1,187 days
    2022-03-31: $437K2022-06-30: $189K2022-09-30: $93K2022-12-31: $11K2023-03-31: $646K2023-06-30: $744K2023-09-30: $695K2024-03-31: $816K2024-06-30: $16.2M
    the quarter ended 30 Jun 20248 earlier quartersnormal: $542K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  17. 13 Jun 2024Insiders record

    Borthwick John (director) bought 7,743 shares of BLDE ($22,997) (dated 12 Jun 2024)

  18. 13 Jun 2024Insiders record

    Love Reginald (director) bought 5,091 shares of BLDE ($15,222) (dated 12 Jun 2024)

  19. 22 Mar 2024Filings record

    Changed its auditor

  20. 15 Nov 2023Insiders record

    Affeldt Eric (director) bought 50,000 shares of BLDE ($160,000) (dated 14 Nov 2023)

  21. 20 Jul 2023Lobbying record

    BOLTON-ST. JOHNS LLC ON BEHALF OF BLADE AIR MOBILITY, INC.: lobbying engagement terminated (MS. MICHELLE NAWAR) (dated 30 Apr 2023)

  22. 20 Jul 2023Lobbying record

    BLADE AIR MOBILITY, INC.: lobbying engagement terminated (BOLTON-ST. JOHNS, LLC) (dated 30 Apr 2023)

  23. 30 Mar 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 30 Mar 2023Filings record

    Director or officer change

  25. 15 Nov 2022Financials change

    reported revenue of $45.7M for the quarter ended 30 Sep 2022, 2.3× the same quarter last year.

    Same quarter last year: $20.3M; its normal quarter is $13.0M.

    See the evidence
    This period
    $45.7M (the quarter ended 30 Sep 2022)
    Normal quarter (median of 7 earlier)
    $13.0M
    Typical spread (median absolute deviation)
    $7.4M
    How far from its usual level
    +3.0
    Same quarter last year
    $20.3M
    History used
    822 days
    2020-06-30: $3.4M2020-09-30: $8.3M2021-03-31: $9.3M2021-06-30: $13.0M2021-09-30: $20.3M2022-03-31: $26.6M2022-06-30: $35.6M2022-09-30: $45.7M
    the quarter ended 30 Sep 20227 earlier quartersnormal: $13.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  26. 2 Jun 2022Lobbying record

    BOLTON-ST. JOHNS LLC ON BEHALF OF BLADE AIR MOBILITY, INC.: new lobbying registration (MS. MICHELLE NAWAR) (dated 10 May 2022)

  27. 1 Jun 2022Lobbying record

    BLADE AIR MOBILITY, INC.: new lobbying registration (BOLTON-ST. JOHNS, LLC) (dated 10 May 2022)

  28. 14 Jan 2022Lobbying record

    BLADE URBAN AIR MOBILITY, INC.: lobbying engagement terminated (INVARIANT LLC) (dated 1 Nov 2021)

  29. 24 Sep 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 24 Sep 2021Filings record

    Director or officer change

  31. 8 Jul 2021Lobbying change

    registered for federal lobbying for the first time in our data (Invariant Llc).

    See the evidence (1 source record)
    Source coverage starts
    6 Apr 2010
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  32. 8 Jul 2021Lobbying record

    BLADE URBAN AIR MOBILITY, INC.: new lobbying registration (INVARIANT LLC) (dated 7 Jun 2021)

  33. 29 May 2021Insiders record

    Affeldt Eric (director) bought 10,000 shares of BLDE ($94,200) (dated 28 May 2021)

  34. 28 May 2021Filings record

    Registered new securities for sale (S-1)

  35. 17 May 2021Filings record

    Report will be filed late

  36. 12 May 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  37. 12 May 2021Filings record

    Director or officer change

  38. 12 May 2021Filings record

    Completed an acquisition or asset sale

  39. 12 May 2021Insiders record

    RESNICK ERIC CHARLES (ten percent owner) and 1 other(s) bought 2,005,000 shares of BLDE ($20.1M) (dated 11 May 2021)

  40. 28 Apr 2021Filings record

    Earlier financial statements can no longer be relied on

Showing the newest 40 of 42 entries; narrow the window or the kind of data to see older ones.

Not listed: 152 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001779128
Ticker
SRTA
Domain
stratacritical.com
Hq location
NY|NEW YORK|10017 (1 unverified)
Lobbying client
axadvocacy government relations on behalf of strata critical, blade air mobility, blade urban air mobility, bolton st johns llc on behalf of blade air mobility and 1 more
Name
Blade Air Mobility, Inc., Experience Investment Corp., Keystone Perfusion Services LLC, Strata Critical, Inc and 3 more
  • Federal lobbying disclosures (LDA)8 records, 33 data points7 Jun 2021 to 30 Sep 2026
  • SEC Form 13F institutional holdings207 data points31 Mar 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)92 records23 Aug 2019 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)451 data points30 Sep 2018 to 26 Oct 2026
  • SEC Form 4 insider transactions83 records, 168 data points11 May 2021 to 9 Nov 2026
  • FINRA short interest (twice monthly)87 data points29 Aug 2025 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)620 data points29 Aug 2025 to 20 Nov 2026